5-Iodo-BIIB021
Based on 1 Customer Validation
5-Iodo-BIIB021 is a HSP90 ligand. 5-Iodo-BIIB021 serves as a Ligand for Target Protein for PROTAC for the synthesis of PROTAC HSP90 degraders, such as PROTAC HSP90 degrader BP3 (HY-115997). 5-Iodo-BIIB021 is applicable to breast cancer research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 911397-54-1
- Formule: C15H15ClIN5O
- Masse moléculaire:443.67
-
Stockage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Activité biologique
Description
IC50 & Target
[1]|
HSP90 |
In Vivo
Chemical Information
-
CAS No. 911397-54-1
-
Appearance Solid
-
Masse moléculaire 443.67
-
Formule C15H15ClIN5O
-
Color White to off-white
-
SMILES
CC1=CN=C(C(=C1OC)C)CN2C=C(C3=C2N=C(N=C3Cl)N)I
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Protocole
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)